Global Group A and C Meningococcal Polysaccharide Vaccine Market Research Report 2025(Status and Outlook)
Report Overview
Group A and C Meningococcal Polysaccharide Vaccine is a biologic product designed to provide active immunization against Neisseria meningitidis serogroups A and C, which are responsible for causing invasive meningococcal disease. This vaccine is formulated using purified polysaccharides extracted from the cell walls of the respective meningococcal strains. By introducing these antigens into the body, the vaccine stimulates the immune system to produce antibodies against the serogroups, thereby offering protection against potential infections. It is typically administered to individuals at increased risk of exposure, such as travelers to endemic areas, military personnel, or those with certain medical conditions that predispose them to meningococcal disease. The vaccine is part of a broader strategy to prevent the spread of meningococcal disease and reduce the incidence of related complications.
This report provides a deep insight into the global Group A and C Meningococcal Polysaccharide Vaccine market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Group A and C Meningococcal Polysaccharide Vaccine Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Group A and C Meningococcal Polysaccharide Vaccine market in any manner.
Global Group A and C Meningococcal Polysaccharide Vaccine Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Pfizer
Sanofi Pasteur
GlaxoSmithKline
Merck & Co.
Royal (Wuxi) Bio-Pharmaceutical
Zhifei Biological
Toyouvax
Walvax
AIM Bio
Lanzhou Institute of Biological Products
Cansino Biologics
Chengda Biotechnology
Sinovac
Market Segmentation (by Type)
Polysaccharide Vaccine
Polysaccharide-protein Conjugate Vaccine
Market Segmentation (by Application)
Hospital
Centers for Disease Control and Prevention
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Group A and C Meningococcal Polysaccharide Vaccine Market
Overview of the regional outlook of the Group A and C Meningococcal Polysaccharide Vaccine Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Group A and C Meningococcal Polysaccharide Vaccine Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Group A and C Meningococcal Polysaccharide Vaccine, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Group A and C Meningococcal Polysaccharide Vaccine is a biologic product designed to provide active immunization against Neisseria meningitidis serogroups A and C, which are responsible for causing invasive meningococcal disease. This vaccine is formulated using purified polysaccharides extracted from the cell walls of the respective meningococcal strains. By introducing these antigens into the body, the vaccine stimulates the immune system to produce antibodies against the serogroups, thereby offering protection against potential infections. It is typically administered to individuals at increased risk of exposure, such as travelers to endemic areas, military personnel, or those with certain medical conditions that predispose them to meningococcal disease. The vaccine is part of a broader strategy to prevent the spread of meningococcal disease and reduce the incidence of related complications.
This report provides a deep insight into the global Group A and C Meningococcal Polysaccharide Vaccine market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Group A and C Meningococcal Polysaccharide Vaccine Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Group A and C Meningococcal Polysaccharide Vaccine market in any manner.
Global Group A and C Meningococcal Polysaccharide Vaccine Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Pfizer
Sanofi Pasteur
GlaxoSmithKline
Merck & Co.
Royal (Wuxi) Bio-Pharmaceutical
Zhifei Biological
Toyouvax
Walvax
AIM Bio
Lanzhou Institute of Biological Products
Cansino Biologics
Chengda Biotechnology
Sinovac
Market Segmentation (by Type)
Polysaccharide Vaccine
Polysaccharide-protein Conjugate Vaccine
Market Segmentation (by Application)
Hospital
Centers for Disease Control and Prevention
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Group A and C Meningococcal Polysaccharide Vaccine Market
Overview of the regional outlook of the Group A and C Meningococcal Polysaccharide Vaccine Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Group A and C Meningococcal Polysaccharide Vaccine Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Group A and C Meningococcal Polysaccharide Vaccine, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Group A and C Meningococcal Polysaccharide Vaccine
1.2 Key Market Segments
1.2.1 Group A and C Meningococcal Polysaccharide Vaccine Segment by Type
1.2.2 Group A and C Meningococcal Polysaccharide Vaccine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 GROUP A AND C MENINGOCOCCAL POLYSACCHARIDE VACCINE MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Group A and C Meningococcal Polysaccharide Vaccine Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Group A and C Meningococcal Polysaccharide Vaccine Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 GROUP A AND C MENINGOCOCCAL POLYSACCHARIDE VACCINE MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Group A and C Meningococcal Polysaccharide Vaccine Product Life Cycle
3.3 Global Group A and C Meningococcal Polysaccharide Vaccine Sales by Manufacturers (2020-2025)
3.4 Global Group A and C Meningococcal Polysaccharide Vaccine Revenue Market Share by Manufacturers (2020-2025)
3.5 Group A and C Meningococcal Polysaccharide Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Group A and C Meningococcal Polysaccharide Vaccine Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Group A and C Meningococcal Polysaccharide Vaccine Market Competitive Situation and Trends
3.8.1 Group A and C Meningococcal Polysaccharide Vaccine Market Concentration Rate
3.8.2 Global 5 and 10 Largest Group A and C Meningococcal Polysaccharide Vaccine Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 GROUP A AND C MENINGOCOCCAL POLYSACCHARIDE VACCINE INDUSTRY CHAIN ANALYSIS
4.1 Group A and C Meningococcal Polysaccharide Vaccine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF GROUP A AND C MENINGOCOCCAL POLYSACCHARIDE VACCINE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Group A and C Meningococcal Polysaccharide Vaccine Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Group A and C Meningococcal Polysaccharide Vaccine Market
5.7 ESG Ratings of Leading Companies
6 GROUP A AND C MENINGOCOCCAL POLYSACCHARIDE VACCINE MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Group A and C Meningococcal Polysaccharide Vaccine Sales Market Share by Type (2020-2025)
6.3 Global Group A and C Meningococcal Polysaccharide Vaccine Market Size Market Share by Type (2020-2025)
6.4 Global Group A and C Meningococcal Polysaccharide Vaccine Price by Type (2020-2025)
7 GROUP A AND C MENINGOCOCCAL POLYSACCHARIDE VACCINE MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Group A and C Meningococcal Polysaccharide Vaccine Market Sales by Application (2020-2025)
7.3 Global Group A and C Meningococcal Polysaccharide Vaccine Market Size (M USD) by Application (2020-2025)
7.4 Global Group A and C Meningococcal Polysaccharide Vaccine Sales Growth Rate by Application (2020-2025)
8 GROUP A AND C MENINGOCOCCAL POLYSACCHARIDE VACCINE MARKET SALES BY REGION
8.1 Global Group A and C Meningococcal Polysaccharide Vaccine Sales by Region
8.1.1 Global Group A and C Meningococcal Polysaccharide Vaccine Sales by Region
8.1.2 Global Group A and C Meningococcal Polysaccharide Vaccine Sales Market Share by Region
8.2 Global Group A and C Meningococcal Polysaccharide Vaccine Market Size by Region
8.2.1 Global Group A and C Meningococcal Polysaccharide Vaccine Market Size by Region
8.2.2 Global Group A and C Meningococcal Polysaccharide Vaccine Market Size Market Share by Region
8.3 North America
8.3.1 North America Group A and C Meningococcal Polysaccharide Vaccine Sales by Country
8.3.2 North America Group A and C Meningococcal Polysaccharide Vaccine Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Group A and C Meningococcal Polysaccharide Vaccine Sales by Country
8.4.2 Europe Group A and C Meningococcal Polysaccharide Vaccine Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Group A and C Meningococcal Polysaccharide Vaccine Sales by Region
8.5.2 Asia Pacific Group A and C Meningococcal Polysaccharide Vaccine Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Group A and C Meningococcal Polysaccharide Vaccine Sales by Country
8.6.2 South America Group A and C Meningococcal Polysaccharide Vaccine Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Group A and C Meningococcal Polysaccharide Vaccine Sales by Region
8.7.2 Middle East and Africa Group A and C Meningococcal Polysaccharide Vaccine Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 GROUP A AND C MENINGOCOCCAL POLYSACCHARIDE VACCINE MARKET PRODUCTION BY REGION
9.1 Global Production of Group A and C Meningococcal Polysaccharide Vaccine by Region(2020-2025)
9.2 Global Group A and C Meningococcal Polysaccharide Vaccine Revenue Market Share by Region (2020-2025)
9.3 Global Group A and C Meningococcal Polysaccharide Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Group A and C Meningococcal Polysaccharide Vaccine Production
9.4.1 North America Group A and C Meningococcal Polysaccharide Vaccine Production Growth Rate (2020-2025)
9.4.2 North America Group A and C Meningococcal Polysaccharide Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Group A and C Meningococcal Polysaccharide Vaccine Production
9.5.1 Europe Group A and C Meningococcal Polysaccharide Vaccine Production Growth Rate (2020-2025)
9.5.2 Europe Group A and C Meningococcal Polysaccharide Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Group A and C Meningococcal Polysaccharide Vaccine Production (2020-2025)
9.6.1 Japan Group A and C Meningococcal Polysaccharide Vaccine Production Growth Rate (2020-2025)
9.6.2 Japan Group A and C Meningococcal Polysaccharide Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Group A and C Meningococcal Polysaccharide Vaccine Production (2020-2025)
9.7.1 China Group A and C Meningococcal Polysaccharide Vaccine Production Growth Rate (2020-2025)
9.7.2 China Group A and C Meningococcal Polysaccharide Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Pfizer
10.1.1 Pfizer Basic Information
10.1.2 Pfizer Group A and C Meningococcal Polysaccharide Vaccine Product Overview
10.1.3 Pfizer Group A and C Meningococcal Polysaccharide Vaccine Product Market Performance
10.1.4 Pfizer Business Overview
10.1.5 Pfizer SWOT Analysis
10.1.6 Pfizer Recent Developments
10.2 Sanofi Pasteur
10.2.1 Sanofi Pasteur Basic Information
10.2.2 Sanofi Pasteur Group A and C Meningococcal Polysaccharide Vaccine Product Overview
10.2.3 Sanofi Pasteur Group A and C Meningococcal Polysaccharide Vaccine Product Market Performance
10.2.4 Sanofi Pasteur Business Overview
10.2.5 Sanofi Pasteur SWOT Analysis
10.2.6 Sanofi Pasteur Recent Developments
10.3 GlaxoSmithKline
10.3.1 GlaxoSmithKline Basic Information
10.3.2 GlaxoSmithKline Group A and C Meningococcal Polysaccharide Vaccine Product Overview
10.3.3 GlaxoSmithKline Group A and C Meningococcal Polysaccharide Vaccine Product Market Performance
10.3.4 GlaxoSmithKline Business Overview
10.3.5 GlaxoSmithKline SWOT Analysis
10.3.6 GlaxoSmithKline Recent Developments
10.4 Merck and Co.
10.4.1 Merck and Co. Basic Information
10.4.2 Merck and Co. Group A and C Meningococcal Polysaccharide Vaccine Product Overview
10.4.3 Merck and Co. Group A and C Meningococcal Polysaccharide Vaccine Product Market Performance
10.4.4 Merck and Co. Business Overview
10.4.5 Merck and Co. Recent Developments
10.5 Royal (Wuxi) Bio-Pharmaceutical
10.5.1 Royal (Wuxi) Bio-Pharmaceutical Basic Information
10.5.2 Royal (Wuxi) Bio-Pharmaceutical Group A and C Meningococcal Polysaccharide Vaccine Product Overview
10.5.3 Royal (Wuxi) Bio-Pharmaceutical Group A and C Meningococcal Polysaccharide Vaccine Product Market Performance
10.5.4 Royal (Wuxi) Bio-Pharmaceutical Business Overview
10.5.5 Royal (Wuxi) Bio-Pharmaceutical Recent Developments
10.6 Zhifei Biological
10.6.1 Zhifei Biological Basic Information
10.6.2 Zhifei Biological Group A and C Meningococcal Polysaccharide Vaccine Product Overview
10.6.3 Zhifei Biological Group A and C Meningococcal Polysaccharide Vaccine Product Market Performance
10.6.4 Zhifei Biological Business Overview
10.6.5 Zhifei Biological Recent Developments
10.7 Toyouvax
10.7.1 Toyouvax Basic Information
10.7.2 Toyouvax Group A and C Meningococcal Polysaccharide Vaccine Product Overview
10.7.3 Toyouvax Group A and C Meningococcal Polysaccharide Vaccine Product Market Performance
10.7.4 Toyouvax Business Overview
10.7.5 Toyouvax Recent Developments
10.8 Walvax
10.8.1 Walvax Basic Information
10.8.2 Walvax Group A and C Meningococcal Polysaccharide Vaccine Product Overview
10.8.3 Walvax Group A and C Meningococcal Polysaccharide Vaccine Product Market Performance
10.8.4 Walvax Business Overview
10.8.5 Walvax Recent Developments
10.9 AIM Bio
10.9.1 AIM Bio Basic Information
10.9.2 AIM Bio Group A and C Meningococcal Polysaccharide Vaccine Product Overview
10.9.3 AIM Bio Group A and C Meningococcal Polysaccharide Vaccine Product Market Performance
10.9.4 AIM Bio Business Overview
10.9.5 AIM Bio Recent Developments
10.10 Lanzhou Institute of Biological Products
10.10.1 Lanzhou Institute of Biological Products Basic Information
10.10.2 Lanzhou Institute of Biological Products Group A and C Meningococcal Polysaccharide Vaccine Product Overview
10.10.3 Lanzhou Institute of Biological Products Group A and C Meningococcal Polysaccharide Vaccine Product Market Performance
10.10.4 Lanzhou Institute of Biological Products Business Overview
10.10.5 Lanzhou Institute of Biological Products Recent Developments
10.11 Cansino Biologics
10.11.1 Cansino Biologics Basic Information
10.11.2 Cansino Biologics Group A and C Meningococcal Polysaccharide Vaccine Product Overview
10.11.3 Cansino Biologics Group A and C Meningococcal Polysaccharide Vaccine Product Market Performance
10.11.4 Cansino Biologics Business Overview
10.11.5 Cansino Biologics Recent Developments
10.12 Chengda Biotechnology
10.12.1 Chengda Biotechnology Basic Information
10.12.2 Chengda Biotechnology Group A and C Meningococcal Polysaccharide Vaccine Product Overview
10.12.3 Chengda Biotechnology Group A and C Meningococcal Polysaccharide Vaccine Product Market Performance
10.12.4 Chengda Biotechnology Business Overview
10.12.5 Chengda Biotechnology Recent Developments
10.13 Sinovac
10.13.1 Sinovac Basic Information
10.13.2 Sinovac Group A and C Meningococcal Polysaccharide Vaccine Product Overview
10.13.3 Sinovac Group A and C Meningococcal Polysaccharide Vaccine Product Market Performance
10.13.4 Sinovac Business Overview
10.13.5 Sinovac Recent Developments
11 GROUP A AND C MENINGOCOCCAL POLYSACCHARIDE VACCINE MARKET FORECAST BY REGION
11.1 Global Group A and C Meningococcal Polysaccharide Vaccine Market Size Forecast
11.2 Global Group A and C Meningococcal Polysaccharide Vaccine Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Group A and C Meningococcal Polysaccharide Vaccine Market Size Forecast by Country
11.2.3 Asia Pacific Group A and C Meningococcal Polysaccharide Vaccine Market Size Forecast by Region
11.2.4 South America Group A and C Meningococcal Polysaccharide Vaccine Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Group A and C Meningococcal Polysaccharide Vaccine by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
12.1 Global Group A and C Meningococcal Polysaccharide Vaccine Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Group A and C Meningococcal Polysaccharide Vaccine by Type (2026-2033)
12.1.2 Global Group A and C Meningococcal Polysaccharide Vaccine Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Group A and C Meningococcal Polysaccharide Vaccine by Type (2026-2033)
12.2 Global Group A and C Meningococcal Polysaccharide Vaccine Market Forecast by Application (2026-2033)
12.2.1 Global Group A and C Meningococcal Polysaccharide Vaccine Sales (K Units) Forecast by Application
12.2.2 Global Group A and C Meningococcal Polysaccharide Vaccine Market Size (M USD) Forecast by Application (2026-2033)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Group A and C Meningococcal Polysaccharide Vaccine
1.2 Key Market Segments
1.2.1 Group A and C Meningococcal Polysaccharide Vaccine Segment by Type
1.2.2 Group A and C Meningococcal Polysaccharide Vaccine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 GROUP A AND C MENINGOCOCCAL POLYSACCHARIDE VACCINE MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Group A and C Meningococcal Polysaccharide Vaccine Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Group A and C Meningococcal Polysaccharide Vaccine Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 GROUP A AND C MENINGOCOCCAL POLYSACCHARIDE VACCINE MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Group A and C Meningococcal Polysaccharide Vaccine Product Life Cycle
3.3 Global Group A and C Meningococcal Polysaccharide Vaccine Sales by Manufacturers (2020-2025)
3.4 Global Group A and C Meningococcal Polysaccharide Vaccine Revenue Market Share by Manufacturers (2020-2025)
3.5 Group A and C Meningococcal Polysaccharide Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Group A and C Meningococcal Polysaccharide Vaccine Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Group A and C Meningococcal Polysaccharide Vaccine Market Competitive Situation and Trends
3.8.1 Group A and C Meningococcal Polysaccharide Vaccine Market Concentration Rate
3.8.2 Global 5 and 10 Largest Group A and C Meningococcal Polysaccharide Vaccine Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 GROUP A AND C MENINGOCOCCAL POLYSACCHARIDE VACCINE INDUSTRY CHAIN ANALYSIS
4.1 Group A and C Meningococcal Polysaccharide Vaccine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF GROUP A AND C MENINGOCOCCAL POLYSACCHARIDE VACCINE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Group A and C Meningococcal Polysaccharide Vaccine Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Group A and C Meningococcal Polysaccharide Vaccine Market
5.7 ESG Ratings of Leading Companies
6 GROUP A AND C MENINGOCOCCAL POLYSACCHARIDE VACCINE MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Group A and C Meningococcal Polysaccharide Vaccine Sales Market Share by Type (2020-2025)
6.3 Global Group A and C Meningococcal Polysaccharide Vaccine Market Size Market Share by Type (2020-2025)
6.4 Global Group A and C Meningococcal Polysaccharide Vaccine Price by Type (2020-2025)
7 GROUP A AND C MENINGOCOCCAL POLYSACCHARIDE VACCINE MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Group A and C Meningococcal Polysaccharide Vaccine Market Sales by Application (2020-2025)
7.3 Global Group A and C Meningococcal Polysaccharide Vaccine Market Size (M USD) by Application (2020-2025)
7.4 Global Group A and C Meningococcal Polysaccharide Vaccine Sales Growth Rate by Application (2020-2025)
8 GROUP A AND C MENINGOCOCCAL POLYSACCHARIDE VACCINE MARKET SALES BY REGION
8.1 Global Group A and C Meningococcal Polysaccharide Vaccine Sales by Region
8.1.1 Global Group A and C Meningococcal Polysaccharide Vaccine Sales by Region
8.1.2 Global Group A and C Meningococcal Polysaccharide Vaccine Sales Market Share by Region
8.2 Global Group A and C Meningococcal Polysaccharide Vaccine Market Size by Region
8.2.1 Global Group A and C Meningococcal Polysaccharide Vaccine Market Size by Region
8.2.2 Global Group A and C Meningococcal Polysaccharide Vaccine Market Size Market Share by Region
8.3 North America
8.3.1 North America Group A and C Meningococcal Polysaccharide Vaccine Sales by Country
8.3.2 North America Group A and C Meningococcal Polysaccharide Vaccine Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Group A and C Meningococcal Polysaccharide Vaccine Sales by Country
8.4.2 Europe Group A and C Meningococcal Polysaccharide Vaccine Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Group A and C Meningococcal Polysaccharide Vaccine Sales by Region
8.5.2 Asia Pacific Group A and C Meningococcal Polysaccharide Vaccine Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Group A and C Meningococcal Polysaccharide Vaccine Sales by Country
8.6.2 South America Group A and C Meningococcal Polysaccharide Vaccine Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Group A and C Meningococcal Polysaccharide Vaccine Sales by Region
8.7.2 Middle East and Africa Group A and C Meningococcal Polysaccharide Vaccine Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 GROUP A AND C MENINGOCOCCAL POLYSACCHARIDE VACCINE MARKET PRODUCTION BY REGION
9.1 Global Production of Group A and C Meningococcal Polysaccharide Vaccine by Region(2020-2025)
9.2 Global Group A and C Meningococcal Polysaccharide Vaccine Revenue Market Share by Region (2020-2025)
9.3 Global Group A and C Meningococcal Polysaccharide Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Group A and C Meningococcal Polysaccharide Vaccine Production
9.4.1 North America Group A and C Meningococcal Polysaccharide Vaccine Production Growth Rate (2020-2025)
9.4.2 North America Group A and C Meningococcal Polysaccharide Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Group A and C Meningococcal Polysaccharide Vaccine Production
9.5.1 Europe Group A and C Meningococcal Polysaccharide Vaccine Production Growth Rate (2020-2025)
9.5.2 Europe Group A and C Meningococcal Polysaccharide Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Group A and C Meningococcal Polysaccharide Vaccine Production (2020-2025)
9.6.1 Japan Group A and C Meningococcal Polysaccharide Vaccine Production Growth Rate (2020-2025)
9.6.2 Japan Group A and C Meningococcal Polysaccharide Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Group A and C Meningococcal Polysaccharide Vaccine Production (2020-2025)
9.7.1 China Group A and C Meningococcal Polysaccharide Vaccine Production Growth Rate (2020-2025)
9.7.2 China Group A and C Meningococcal Polysaccharide Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Pfizer
10.1.1 Pfizer Basic Information
10.1.2 Pfizer Group A and C Meningococcal Polysaccharide Vaccine Product Overview
10.1.3 Pfizer Group A and C Meningococcal Polysaccharide Vaccine Product Market Performance
10.1.4 Pfizer Business Overview
10.1.5 Pfizer SWOT Analysis
10.1.6 Pfizer Recent Developments
10.2 Sanofi Pasteur
10.2.1 Sanofi Pasteur Basic Information
10.2.2 Sanofi Pasteur Group A and C Meningococcal Polysaccharide Vaccine Product Overview
10.2.3 Sanofi Pasteur Group A and C Meningococcal Polysaccharide Vaccine Product Market Performance
10.2.4 Sanofi Pasteur Business Overview
10.2.5 Sanofi Pasteur SWOT Analysis
10.2.6 Sanofi Pasteur Recent Developments
10.3 GlaxoSmithKline
10.3.1 GlaxoSmithKline Basic Information
10.3.2 GlaxoSmithKline Group A and C Meningococcal Polysaccharide Vaccine Product Overview
10.3.3 GlaxoSmithKline Group A and C Meningococcal Polysaccharide Vaccine Product Market Performance
10.3.4 GlaxoSmithKline Business Overview
10.3.5 GlaxoSmithKline SWOT Analysis
10.3.6 GlaxoSmithKline Recent Developments
10.4 Merck and Co.
10.4.1 Merck and Co. Basic Information
10.4.2 Merck and Co. Group A and C Meningococcal Polysaccharide Vaccine Product Overview
10.4.3 Merck and Co. Group A and C Meningococcal Polysaccharide Vaccine Product Market Performance
10.4.4 Merck and Co. Business Overview
10.4.5 Merck and Co. Recent Developments
10.5 Royal (Wuxi) Bio-Pharmaceutical
10.5.1 Royal (Wuxi) Bio-Pharmaceutical Basic Information
10.5.2 Royal (Wuxi) Bio-Pharmaceutical Group A and C Meningococcal Polysaccharide Vaccine Product Overview
10.5.3 Royal (Wuxi) Bio-Pharmaceutical Group A and C Meningococcal Polysaccharide Vaccine Product Market Performance
10.5.4 Royal (Wuxi) Bio-Pharmaceutical Business Overview
10.5.5 Royal (Wuxi) Bio-Pharmaceutical Recent Developments
10.6 Zhifei Biological
10.6.1 Zhifei Biological Basic Information
10.6.2 Zhifei Biological Group A and C Meningococcal Polysaccharide Vaccine Product Overview
10.6.3 Zhifei Biological Group A and C Meningococcal Polysaccharide Vaccine Product Market Performance
10.6.4 Zhifei Biological Business Overview
10.6.5 Zhifei Biological Recent Developments
10.7 Toyouvax
10.7.1 Toyouvax Basic Information
10.7.2 Toyouvax Group A and C Meningococcal Polysaccharide Vaccine Product Overview
10.7.3 Toyouvax Group A and C Meningococcal Polysaccharide Vaccine Product Market Performance
10.7.4 Toyouvax Business Overview
10.7.5 Toyouvax Recent Developments
10.8 Walvax
10.8.1 Walvax Basic Information
10.8.2 Walvax Group A and C Meningococcal Polysaccharide Vaccine Product Overview
10.8.3 Walvax Group A and C Meningococcal Polysaccharide Vaccine Product Market Performance
10.8.4 Walvax Business Overview
10.8.5 Walvax Recent Developments
10.9 AIM Bio
10.9.1 AIM Bio Basic Information
10.9.2 AIM Bio Group A and C Meningococcal Polysaccharide Vaccine Product Overview
10.9.3 AIM Bio Group A and C Meningococcal Polysaccharide Vaccine Product Market Performance
10.9.4 AIM Bio Business Overview
10.9.5 AIM Bio Recent Developments
10.10 Lanzhou Institute of Biological Products
10.10.1 Lanzhou Institute of Biological Products Basic Information
10.10.2 Lanzhou Institute of Biological Products Group A and C Meningococcal Polysaccharide Vaccine Product Overview
10.10.3 Lanzhou Institute of Biological Products Group A and C Meningococcal Polysaccharide Vaccine Product Market Performance
10.10.4 Lanzhou Institute of Biological Products Business Overview
10.10.5 Lanzhou Institute of Biological Products Recent Developments
10.11 Cansino Biologics
10.11.1 Cansino Biologics Basic Information
10.11.2 Cansino Biologics Group A and C Meningococcal Polysaccharide Vaccine Product Overview
10.11.3 Cansino Biologics Group A and C Meningococcal Polysaccharide Vaccine Product Market Performance
10.11.4 Cansino Biologics Business Overview
10.11.5 Cansino Biologics Recent Developments
10.12 Chengda Biotechnology
10.12.1 Chengda Biotechnology Basic Information
10.12.2 Chengda Biotechnology Group A and C Meningococcal Polysaccharide Vaccine Product Overview
10.12.3 Chengda Biotechnology Group A and C Meningococcal Polysaccharide Vaccine Product Market Performance
10.12.4 Chengda Biotechnology Business Overview
10.12.5 Chengda Biotechnology Recent Developments
10.13 Sinovac
10.13.1 Sinovac Basic Information
10.13.2 Sinovac Group A and C Meningococcal Polysaccharide Vaccine Product Overview
10.13.3 Sinovac Group A and C Meningococcal Polysaccharide Vaccine Product Market Performance
10.13.4 Sinovac Business Overview
10.13.5 Sinovac Recent Developments
11 GROUP A AND C MENINGOCOCCAL POLYSACCHARIDE VACCINE MARKET FORECAST BY REGION
11.1 Global Group A and C Meningococcal Polysaccharide Vaccine Market Size Forecast
11.2 Global Group A and C Meningococcal Polysaccharide Vaccine Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Group A and C Meningococcal Polysaccharide Vaccine Market Size Forecast by Country
11.2.3 Asia Pacific Group A and C Meningococcal Polysaccharide Vaccine Market Size Forecast by Region
11.2.4 South America Group A and C Meningococcal Polysaccharide Vaccine Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Group A and C Meningococcal Polysaccharide Vaccine by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
12.1 Global Group A and C Meningococcal Polysaccharide Vaccine Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Group A and C Meningococcal Polysaccharide Vaccine by Type (2026-2033)
12.1.2 Global Group A and C Meningococcal Polysaccharide Vaccine Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Group A and C Meningococcal Polysaccharide Vaccine by Type (2026-2033)
12.2 Global Group A and C Meningococcal Polysaccharide Vaccine Market Forecast by Application (2026-2033)
12.2.1 Global Group A and C Meningococcal Polysaccharide Vaccine Sales (K Units) Forecast by Application
12.2.2 Global Group A and C Meningococcal Polysaccharide Vaccine Market Size (M USD) Forecast by Application (2026-2033)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Group A and C Meningococcal Polysaccharide Vaccine Market Size Comparison by Region (M USD)
Table 5. Global Group A and C Meningococcal Polysaccharide Vaccine Sales (K Units) by Manufacturers (2020-2025)
Table 6. Global Group A and C Meningococcal Polysaccharide Vaccine Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Group A and C Meningococcal Polysaccharide Vaccine Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Group A and C Meningococcal Polysaccharide Vaccine Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Group A and C Meningococcal Polysaccharide Vaccine as of 2024)
Table 10. Global Market Group A and C Meningococcal Polysaccharide Vaccine Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 11. Manufacturers? Manufacturing Sites, Areas Served
Table 12. Manufacturers? Product Type
Table 13. Global Group A and C Meningococcal Polysaccharide Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Group A and C Meningococcal Polysaccharide Vaccine Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 25. Global Group A and C Meningococcal Polysaccharide Vaccine Sales by Type (K Units)
Table 26. Global Group A and C Meningococcal Polysaccharide Vaccine Market Size by Type (M USD)
Table 27. Global Group A and C Meningococcal Polysaccharide Vaccine Sales (K Units) by Type (2020-2025)
Table 28. Global Group A and C Meningococcal Polysaccharide Vaccine Sales Market Share by Type (2020-2025)
Table 29. Global Group A and C Meningococcal Polysaccharide Vaccine Market Size (M USD) by Type (2020-2025)
Table 30. Global Group A and C Meningococcal Polysaccharide Vaccine Market Size Share by Type (2020-2025)
Table 31. Global Group A and C Meningococcal Polysaccharide Vaccine Price (USD/Unit) by Type (2020-2025)
Table 32. Global Group A and C Meningococcal Polysaccharide Vaccine Sales (K Units) by Application
Table 33. Global Group A and C Meningococcal Polysaccharide Vaccine Market Size by Application
Table 34. Global Group A and C Meningococcal Polysaccharide Vaccine Sales by Application (2020-2025) & (K Units)
Table 35. Global Group A and C Meningococcal Polysaccharide Vaccine Sales Market Share by Application (2020-2025)
Table 36. Global Group A and C Meningococcal Polysaccharide Vaccine Market Size by Application (2020-2025) & (M USD)
Table 37. Global Group A and C Meningococcal Polysaccharide Vaccine Market Share by Application (2020-2025)
Table 38. Global Group A and C Meningococcal Polysaccharide Vaccine Sales Growth Rate by Application (2020-2025)
Table 39. Global Group A and C Meningococcal Polysaccharide Vaccine Sales by Region (2020-2025) & (K Units)
Table 40. Global Group A and C Meningococcal Polysaccharide Vaccine Sales Market Share by Region (2020-2025)
Table 41. Global Group A and C Meningococcal Polysaccharide Vaccine Market Size by Region (2020-2025) & (M USD)
Table 42. Global Group A and C Meningococcal Polysaccharide Vaccine Market Size Market Share by Region (2020-2025)
Table 43. North America Group A and C Meningococcal Polysaccharide Vaccine Sales by Country (2020-2025) & (K Units)
Table 44. North America Group A and C Meningococcal Polysaccharide Vaccine Market Size by Country (2020-2025) & (M USD)
Table 45. Europe Group A and C Meningococcal Polysaccharide Vaccine Sales by Country (2020-2025) & (K Units)
Table 46. Europe Group A and C Meningococcal Polysaccharide Vaccine Market Size by Country (2020-2025) & (M USD)
Table 47. Asia Pacific Group A and C Meningococcal Polysaccharide Vaccine Sales by Region (2020-2025) & (K Units)
Table 48. Asia Pacific Group A and C Meningococcal Polysaccharide Vaccine Market Size by Region (2020-2025) & (M USD)
Table 49. South America Group A and C Meningococcal Polysaccharide Vaccine Sales by Country (2020-2025) & (K Units)
Table 50. South America Group A and C Meningococcal Polysaccharide Vaccine Market Size by Country (2020-2025) & (M USD)
Table 51. Middle East and Africa Group A and C Meningococcal Polysaccharide Vaccine Sales by Region (2020-2025) & (K Units)
Table 52. Middle East and Africa Group A and C Meningococcal Polysaccharide Vaccine Market Size by Region (2020-2025) & (M USD)
Table 53. Global Group A and C Meningococcal Polysaccharide Vaccine Production (K Units) by Region(2020-2025)
Table 54. Global Group A and C Meningococcal Polysaccharide Vaccine Revenue (US$ Million) by Region (2020-2025)
Table 55. Global Group A and C Meningococcal Polysaccharide Vaccine Revenue Market Share by Region (2020-2025)
Table 56. Global Group A and C Meningococcal Polysaccharide Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 57. North America Group A and C Meningococcal Polysaccharide Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. Europe Group A and C Meningococcal Polysaccharide Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Japan Group A and C Meningococcal Polysaccharide Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. China Group A and C Meningococcal Polysaccharide Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. Pfizer Basic Information
Table 62. Pfizer Group A and C Meningococcal Polysaccharide Vaccine Product Overview
Table 63. Pfizer Group A and C Meningococcal Polysaccharide Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 64. Pfizer Business Overview
Table 65. Pfizer SWOT Analysis
Table 66. Pfizer Recent Developments
Table 67. Sanofi Pasteur Basic Information
Table 68. Sanofi Pasteur Group A and C Meningococcal Polysaccharide Vaccine Product Overview
Table 69. Sanofi Pasteur Group A and C Meningococcal Polysaccharide Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 70. Sanofi Pasteur Business Overview
Table 71. Sanofi Pasteur SWOT Analysis
Table 72. Sanofi Pasteur Recent Developments
Table 73. GlaxoSmithKline Basic Information
Table 74. GlaxoSmithKline Group A and C Meningococcal Polysaccharide Vaccine Product Overview
Table 75. GlaxoSmithKline Group A and C Meningococcal Polysaccharide Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 76. GlaxoSmithKline Business Overview
Table 77. GlaxoSmithKline SWOT Analysis
Table 78. GlaxoSmithKline Recent Developments
Table 79. Merck and Co. Basic Information
Table 80. Merck and Co. Group A and C Meningococcal Polysaccharide Vaccine Product Overview
Table 81. Merck and Co. Group A and C Meningococcal Polysaccharide Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 82. Merck and Co. Business Overview
Table 83. Merck and Co. Recent Developments
Table 84. Royal (Wuxi) Bio-Pharmaceutical Basic Information
Table 85. Royal (Wuxi) Bio-Pharmaceutical Group A and C Meningococcal Polysaccharide Vaccine Product Overview
Table 86. Royal (Wuxi) Bio-Pharmaceutical Group A and C Meningococcal Polysaccharide Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 87. Royal (Wuxi) Bio-Pharmaceutical Business Overview
Table 88. Royal (Wuxi) Bio-Pharmaceutical Recent Developments
Table 89. Zhifei Biological Basic Information
Table 90. Zhifei Biological Group A and C Meningococcal Polysaccharide Vaccine Product Overview
Table 91. Zhifei Biological Group A and C Meningococcal Polysaccharide Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 92. Zhifei Biological Business Overview
Table 93. Zhifei Biological Recent Developments
Table 94. Toyouvax Basic Information
Table 95. Toyouvax Group A and C Meningococcal Polysaccharide Vaccine Product Overview
Table 96. Toyouvax Group A and C Meningococcal Polysaccharide Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 97. Toyouvax Business Overview
Table 98. Toyouvax Recent Developments
Table 99. Walvax Basic Information
Table 100. Walvax Group A and C Meningococcal Polysaccharide Vaccine Product Overview
Table 101. Walvax Group A and C Meningococcal Polysaccharide Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 102. Walvax Business Overview
Table 103. Walvax Recent Developments
Table 104. AIM Bio Basic Information
Table 105. AIM Bio Group A and C Meningococcal Polysaccharide Vaccine Product Overview
Table 106. AIM Bio Group A and C Meningococcal Polysaccharide Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 107. AIM Bio Business Overview
Table 108. AIM Bio Recent Developments
Table 109. Lanzhou Institute of Biological Products Basic Information
Table 110. Lanzhou Institute of Biological Products Group A and C Meningococcal Polysaccharide Vaccine Product Overview
Table 111. Lanzhou Institute of Biological Products Group A and C Meningococcal Polysaccharide Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 112. Lanzhou Institute of Biological Products Business Overview
Table 113. Lanzhou Institute of Biological Products Recent Developments
Table 114. Cansino Biologics Basic Information
Table 115. Cansino Biologics Group A and C Meningococcal Polysaccharide Vaccine Product Overview
Table 116. Cansino Biologics Group A and C Meningococcal Polysaccharide Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 117. Cansino Biologics Business Overview
Table 118. Cansino Biologics Recent Developments
Table 119. Chengda Biotechnology Basic Information
Table 120. Chengda Biotechnology Group A and C Meningococcal Polysaccharide Vaccine Product Overview
Table 121. Chengda Biotechnology Group A and C Meningococcal Polysaccharide Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 122. Chengda Biotechnology Business Overview
Table 123. Chengda Biotechnology Recent Developments
Table 124. Sinovac Basic Information
Table 125. Sinovac Group A and C Meningococcal Polysaccharide Vaccine Product Overview
Table 126. Sinovac Group A and C Meningococcal Polysaccharide Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 127. Sinovac Business Overview
Table 128. Sinovac Recent Developments
Table 129. Global Group A and C Meningococcal Polysaccharide Vaccine Sales Forecast by Region (2026-2033) & (K Units)
Table 130. Global Group A and C Meningococcal Polysaccharide Vaccine Market Size Forecast by Region (2026-2033) & (M USD)
Table 131. North America Group A and C Meningococcal Polysaccharide Vaccine Sales Forecast by Country (2026-2033) & (K Units)
Table 132. North America Group A and C Meningococcal Polysaccharide Vaccine Market Size Forecast by Country (2026-2033) & (M USD)
Table 133. Europe Group A and C Meningococcal Polysaccharide Vaccine Sales Forecast by Country (2026-2033) & (K Units)
Table 134. Europe Group A and C Meningococcal Polysaccharide Vaccine Market Size Forecast by Country (2026-2033) & (M USD)
Table 135. Asia Pacific Group A and C Meningococcal Polysaccharide Vaccine Sales Forecast by Region (2026-2033) & (K Units)
Table 136. Asia Pacific Group A and C Meningococcal Polysaccharide Vaccine Market Size Forecast by Region (2026-2033) & (M USD)
Table 137. South America Group A and C Meningococcal Polysaccharide Vaccine Sales Forecast by Country (2026-2033) & (K Units)
Table 138. South America Group A and C Meningococcal Polysaccharide Vaccine Market Size Forecast by Country (2026-2033) & (M USD)
Table 139. Middle East and Africa Group A and C Meningococcal Polysaccharide Vaccine Sales Forecast by Country (2026-2033) & (Units)
Table 140. Middle East and Africa Group A and C Meningococcal Polysaccharide Vaccine Market Size Forecast by Country (2026-2033) & (M USD)
Table 141. Global Group A and C Meningococcal Polysaccharide Vaccine Sales Forecast by Type (2026-2033) & (K Units)
Table 142. Global Group A and C Meningococcal Polysaccharide Vaccine Market Size Forecast by Type (2026-2033) & (M USD)
Table 143. Global Group A and C Meningococcal Polysaccharide Vaccine Price Forecast by Type (2026-2033) & (USD/Unit)
Table 144. Global Group A and C Meningococcal Polysaccharide Vaccine Sales (K Units) Forecast by Application (2026-2033)
Table 145. Global Group A and C Meningococcal Polysaccharide Vaccine Market Size Forecast by Application (2026-2033) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Group A and C Meningococcal Polysaccharide Vaccine Market Size Comparison by Region (M USD)
Table 5. Global Group A and C Meningococcal Polysaccharide Vaccine Sales (K Units) by Manufacturers (2020-2025)
Table 6. Global Group A and C Meningococcal Polysaccharide Vaccine Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Group A and C Meningococcal Polysaccharide Vaccine Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Group A and C Meningococcal Polysaccharide Vaccine Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Group A and C Meningococcal Polysaccharide Vaccine as of 2024)
Table 10. Global Market Group A and C Meningococcal Polysaccharide Vaccine Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 11. Manufacturers? Manufacturing Sites, Areas Served
Table 12. Manufacturers? Product Type
Table 13. Global Group A and C Meningococcal Polysaccharide Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Group A and C Meningococcal Polysaccharide Vaccine Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 25. Global Group A and C Meningococcal Polysaccharide Vaccine Sales by Type (K Units)
Table 26. Global Group A and C Meningococcal Polysaccharide Vaccine Market Size by Type (M USD)
Table 27. Global Group A and C Meningococcal Polysaccharide Vaccine Sales (K Units) by Type (2020-2025)
Table 28. Global Group A and C Meningococcal Polysaccharide Vaccine Sales Market Share by Type (2020-2025)
Table 29. Global Group A and C Meningococcal Polysaccharide Vaccine Market Size (M USD) by Type (2020-2025)
Table 30. Global Group A and C Meningococcal Polysaccharide Vaccine Market Size Share by Type (2020-2025)
Table 31. Global Group A and C Meningococcal Polysaccharide Vaccine Price (USD/Unit) by Type (2020-2025)
Table 32. Global Group A and C Meningococcal Polysaccharide Vaccine Sales (K Units) by Application
Table 33. Global Group A and C Meningococcal Polysaccharide Vaccine Market Size by Application
Table 34. Global Group A and C Meningococcal Polysaccharide Vaccine Sales by Application (2020-2025) & (K Units)
Table 35. Global Group A and C Meningococcal Polysaccharide Vaccine Sales Market Share by Application (2020-2025)
Table 36. Global Group A and C Meningococcal Polysaccharide Vaccine Market Size by Application (2020-2025) & (M USD)
Table 37. Global Group A and C Meningococcal Polysaccharide Vaccine Market Share by Application (2020-2025)
Table 38. Global Group A and C Meningococcal Polysaccharide Vaccine Sales Growth Rate by Application (2020-2025)
Table 39. Global Group A and C Meningococcal Polysaccharide Vaccine Sales by Region (2020-2025) & (K Units)
Table 40. Global Group A and C Meningococcal Polysaccharide Vaccine Sales Market Share by Region (2020-2025)
Table 41. Global Group A and C Meningococcal Polysaccharide Vaccine Market Size by Region (2020-2025) & (M USD)
Table 42. Global Group A and C Meningococcal Polysaccharide Vaccine Market Size Market Share by Region (2020-2025)
Table 43. North America Group A and C Meningococcal Polysaccharide Vaccine Sales by Country (2020-2025) & (K Units)
Table 44. North America Group A and C Meningococcal Polysaccharide Vaccine Market Size by Country (2020-2025) & (M USD)
Table 45. Europe Group A and C Meningococcal Polysaccharide Vaccine Sales by Country (2020-2025) & (K Units)
Table 46. Europe Group A and C Meningococcal Polysaccharide Vaccine Market Size by Country (2020-2025) & (M USD)
Table 47. Asia Pacific Group A and C Meningococcal Polysaccharide Vaccine Sales by Region (2020-2025) & (K Units)
Table 48. Asia Pacific Group A and C Meningococcal Polysaccharide Vaccine Market Size by Region (2020-2025) & (M USD)
Table 49. South America Group A and C Meningococcal Polysaccharide Vaccine Sales by Country (2020-2025) & (K Units)
Table 50. South America Group A and C Meningococcal Polysaccharide Vaccine Market Size by Country (2020-2025) & (M USD)
Table 51. Middle East and Africa Group A and C Meningococcal Polysaccharide Vaccine Sales by Region (2020-2025) & (K Units)
Table 52. Middle East and Africa Group A and C Meningococcal Polysaccharide Vaccine Market Size by Region (2020-2025) & (M USD)
Table 53. Global Group A and C Meningococcal Polysaccharide Vaccine Production (K Units) by Region(2020-2025)
Table 54. Global Group A and C Meningococcal Polysaccharide Vaccine Revenue (US$ Million) by Region (2020-2025)
Table 55. Global Group A and C Meningococcal Polysaccharide Vaccine Revenue Market Share by Region (2020-2025)
Table 56. Global Group A and C Meningococcal Polysaccharide Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 57. North America Group A and C Meningococcal Polysaccharide Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. Europe Group A and C Meningococcal Polysaccharide Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Japan Group A and C Meningococcal Polysaccharide Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. China Group A and C Meningococcal Polysaccharide Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. Pfizer Basic Information
Table 62. Pfizer Group A and C Meningococcal Polysaccharide Vaccine Product Overview
Table 63. Pfizer Group A and C Meningococcal Polysaccharide Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 64. Pfizer Business Overview
Table 65. Pfizer SWOT Analysis
Table 66. Pfizer Recent Developments
Table 67. Sanofi Pasteur Basic Information
Table 68. Sanofi Pasteur Group A and C Meningococcal Polysaccharide Vaccine Product Overview
Table 69. Sanofi Pasteur Group A and C Meningococcal Polysaccharide Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 70. Sanofi Pasteur Business Overview
Table 71. Sanofi Pasteur SWOT Analysis
Table 72. Sanofi Pasteur Recent Developments
Table 73. GlaxoSmithKline Basic Information
Table 74. GlaxoSmithKline Group A and C Meningococcal Polysaccharide Vaccine Product Overview
Table 75. GlaxoSmithKline Group A and C Meningococcal Polysaccharide Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 76. GlaxoSmithKline Business Overview
Table 77. GlaxoSmithKline SWOT Analysis
Table 78. GlaxoSmithKline Recent Developments
Table 79. Merck and Co. Basic Information
Table 80. Merck and Co. Group A and C Meningococcal Polysaccharide Vaccine Product Overview
Table 81. Merck and Co. Group A and C Meningococcal Polysaccharide Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 82. Merck and Co. Business Overview
Table 83. Merck and Co. Recent Developments
Table 84. Royal (Wuxi) Bio-Pharmaceutical Basic Information
Table 85. Royal (Wuxi) Bio-Pharmaceutical Group A and C Meningococcal Polysaccharide Vaccine Product Overview
Table 86. Royal (Wuxi) Bio-Pharmaceutical Group A and C Meningococcal Polysaccharide Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 87. Royal (Wuxi) Bio-Pharmaceutical Business Overview
Table 88. Royal (Wuxi) Bio-Pharmaceutical Recent Developments
Table 89. Zhifei Biological Basic Information
Table 90. Zhifei Biological Group A and C Meningococcal Polysaccharide Vaccine Product Overview
Table 91. Zhifei Biological Group A and C Meningococcal Polysaccharide Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 92. Zhifei Biological Business Overview
Table 93. Zhifei Biological Recent Developments
Table 94. Toyouvax Basic Information
Table 95. Toyouvax Group A and C Meningococcal Polysaccharide Vaccine Product Overview
Table 96. Toyouvax Group A and C Meningococcal Polysaccharide Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 97. Toyouvax Business Overview
Table 98. Toyouvax Recent Developments
Table 99. Walvax Basic Information
Table 100. Walvax Group A and C Meningococcal Polysaccharide Vaccine Product Overview
Table 101. Walvax Group A and C Meningococcal Polysaccharide Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 102. Walvax Business Overview
Table 103. Walvax Recent Developments
Table 104. AIM Bio Basic Information
Table 105. AIM Bio Group A and C Meningococcal Polysaccharide Vaccine Product Overview
Table 106. AIM Bio Group A and C Meningococcal Polysaccharide Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 107. AIM Bio Business Overview
Table 108. AIM Bio Recent Developments
Table 109. Lanzhou Institute of Biological Products Basic Information
Table 110. Lanzhou Institute of Biological Products Group A and C Meningococcal Polysaccharide Vaccine Product Overview
Table 111. Lanzhou Institute of Biological Products Group A and C Meningococcal Polysaccharide Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 112. Lanzhou Institute of Biological Products Business Overview
Table 113. Lanzhou Institute of Biological Products Recent Developments
Table 114. Cansino Biologics Basic Information
Table 115. Cansino Biologics Group A and C Meningococcal Polysaccharide Vaccine Product Overview
Table 116. Cansino Biologics Group A and C Meningococcal Polysaccharide Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 117. Cansino Biologics Business Overview
Table 118. Cansino Biologics Recent Developments
Table 119. Chengda Biotechnology Basic Information
Table 120. Chengda Biotechnology Group A and C Meningococcal Polysaccharide Vaccine Product Overview
Table 121. Chengda Biotechnology Group A and C Meningococcal Polysaccharide Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 122. Chengda Biotechnology Business Overview
Table 123. Chengda Biotechnology Recent Developments
Table 124. Sinovac Basic Information
Table 125. Sinovac Group A and C Meningococcal Polysaccharide Vaccine Product Overview
Table 126. Sinovac Group A and C Meningococcal Polysaccharide Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 127. Sinovac Business Overview
Table 128. Sinovac Recent Developments
Table 129. Global Group A and C Meningococcal Polysaccharide Vaccine Sales Forecast by Region (2026-2033) & (K Units)
Table 130. Global Group A and C Meningococcal Polysaccharide Vaccine Market Size Forecast by Region (2026-2033) & (M USD)
Table 131. North America Group A and C Meningococcal Polysaccharide Vaccine Sales Forecast by Country (2026-2033) & (K Units)
Table 132. North America Group A and C Meningococcal Polysaccharide Vaccine Market Size Forecast by Country (2026-2033) & (M USD)
Table 133. Europe Group A and C Meningococcal Polysaccharide Vaccine Sales Forecast by Country (2026-2033) & (K Units)
Table 134. Europe Group A and C Meningococcal Polysaccharide Vaccine Market Size Forecast by Country (2026-2033) & (M USD)
Table 135. Asia Pacific Group A and C Meningococcal Polysaccharide Vaccine Sales Forecast by Region (2026-2033) & (K Units)
Table 136. Asia Pacific Group A and C Meningococcal Polysaccharide Vaccine Market Size Forecast by Region (2026-2033) & (M USD)
Table 137. South America Group A and C Meningococcal Polysaccharide Vaccine Sales Forecast by Country (2026-2033) & (K Units)
Table 138. South America Group A and C Meningococcal Polysaccharide Vaccine Market Size Forecast by Country (2026-2033) & (M USD)
Table 139. Middle East and Africa Group A and C Meningococcal Polysaccharide Vaccine Sales Forecast by Country (2026-2033) & (Units)
Table 140. Middle East and Africa Group A and C Meningococcal Polysaccharide Vaccine Market Size Forecast by Country (2026-2033) & (M USD)
Table 141. Global Group A and C Meningococcal Polysaccharide Vaccine Sales Forecast by Type (2026-2033) & (K Units)
Table 142. Global Group A and C Meningococcal Polysaccharide Vaccine Market Size Forecast by Type (2026-2033) & (M USD)
Table 143. Global Group A and C Meningococcal Polysaccharide Vaccine Price Forecast by Type (2026-2033) & (USD/Unit)
Table 144. Global Group A and C Meningococcal Polysaccharide Vaccine Sales (K Units) Forecast by Application (2026-2033)
Table 145. Global Group A and C Meningococcal Polysaccharide Vaccine Market Size Forecast by Application (2026-2033) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Group A and C Meningococcal Polysaccharide Vaccine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Group A and C Meningococcal Polysaccharide Vaccine Market Size (M USD), 2024-2033
Figure 5. Global Group A and C Meningococcal Polysaccharide Vaccine Market Size (M USD) (2020-2033)
Figure 6. Global Group A and C Meningococcal Polysaccharide Vaccine Sales (K Units) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Group A and C Meningococcal Polysaccharide Vaccine Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Group A and C Meningococcal Polysaccharide Vaccine Product Life Cycle
Figure 13. Group A and C Meningococcal Polysaccharide Vaccine Sales Share by Manufacturers in 2024
Figure 14. Global Group A and C Meningococcal Polysaccharide Vaccine Revenue Share by Manufacturers in 2024
Figure 15. Group A and C Meningococcal Polysaccharide Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Group A and C Meningococcal Polysaccharide Vaccine Average Price (USD/Unit) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Group A and C Meningococcal Polysaccharide Vaccine Revenue in 2024
Figure 18. Industry Chain Map of Group A and C Meningococcal Polysaccharide Vaccine
Figure 19. Global Group A and C Meningococcal Polysaccharide Vaccine Market PEST Analysis
Figure 20. Global Group A and C Meningococcal Polysaccharide Vaccine Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Group A and C Meningococcal Polysaccharide Vaccine Market Share by Type
Figure 27. Sales Market Share of Group A and C Meningococcal Polysaccharide Vaccine by Type (2020-2025)
Figure 28. Sales Market Share of Group A and C Meningococcal Polysaccharide Vaccine by Type in 2024
Figure 29. Market Size Share of Group A and C Meningococcal Polysaccharide Vaccine by Type (2020-2025)
Figure 30. Market Size Share of Group A and C Meningococcal Polysaccharide Vaccine by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Group A and C Meningococcal Polysaccharide Vaccine Market Share by Application
Figure 33. Global Group A and C Meningococcal Polysaccharide Vaccine Sales Market Share by Application (2020-2025)
Figure 34. Global Group A and C Meningococcal Polysaccharide Vaccine Sales Market Share by Application in 2024
Figure 35. Global Group A and C Meningococcal Polysaccharide Vaccine Market Share by Application (2020-2025)
Figure 36. Global Group A and C Meningococcal Polysaccharide Vaccine Market Share by Application in 2024
Figure 37. Global Group A and C Meningococcal Polysaccharide Vaccine Sales Growth Rate by Application (2020-2025)
Figure 38. Global Group A and C Meningococcal Polysaccharide Vaccine Sales Market Share by Region (2020-2025)
Figure 39. Global Group A and C Meningococcal Polysaccharide Vaccine Market Size Market Share by Region (2020-2025)
Figure 40. North America Group A and C Meningococcal Polysaccharide Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Group A and C Meningococcal Polysaccharide Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Group A and C Meningococcal Polysaccharide Vaccine Sales Market Share by Country in 2024
Figure 43. North America Group A and C Meningococcal Polysaccharide Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Group A and C Meningococcal Polysaccharide Vaccine Market Size Market Share by Country in 2024
Figure 45. U.S. Group A and C Meningococcal Polysaccharide Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Group A and C Meningococcal Polysaccharide Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Group A and C Meningococcal Polysaccharide Vaccine Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Group A and C Meningococcal Polysaccharide Vaccine Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Group A and C Meningococcal Polysaccharide Vaccine Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Group A and C Meningococcal Polysaccharide Vaccine Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Group A and C Meningococcal Polysaccharide Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Group A and C Meningococcal Polysaccharide Vaccine Sales Market Share by Country in 2024
Figure 53. Europe Group A and C Meningococcal Polysaccharide Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Group A and C Meningococcal Polysaccharide Vaccine Market Size Market Share by Country in 2024
Figure 55. Germany Group A and C Meningococcal Polysaccharide Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Group A and C Meningococcal Polysaccharide Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Group A and C Meningococcal Polysaccharide Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Group A and C Meningococcal Polysaccharide Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Group A and C Meningococcal Polysaccharide Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Group A and C Meningococcal Polysaccharide Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Group A and C Meningococcal Polysaccharide Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Group A and C Meningococcal Polysaccharide Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Group A and C Meningococcal Polysaccharide Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Group A and C Meningococcal Polysaccharide Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Group A and C Meningococcal Polysaccharide Vaccine Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Group A and C Meningococcal Polysaccharide Vaccine Sales Market Share by Region in 2024
Figure 67. Asia Pacific Group A and C Meningococcal Polysaccharide Vaccine Market Size Market Share by Region in 2024
Figure 68. China Group A and C Meningococcal Polysaccharide Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Group A and C Meningococcal Polysaccharide Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Group A and C Meningococcal Polysaccharide Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Group A and C Meningococcal Polysaccharide Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Group A and C Meningococcal Polysaccharide Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Group A and C Meningococcal Polysaccharide Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Group A and C Meningococcal Polysaccharide Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Group A and C Meningococcal Polysaccharide Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Group A and C Meningococcal Polysaccharide Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Group A and C Meningococcal Polysaccharide Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Group A and C Meningococcal Polysaccharide Vaccine Sales and Growth Rate (K Units)
Figure 79. South America Group A and C Meningococcal Polysaccharide Vaccine Sales Market Share by Country in 2024
Figure 80. South America Group A and C Meningococcal Polysaccharide Vaccine Market Size and Growth Rate (M USD)
Figure 81. South America Group A and C Meningococcal Polysaccharide Vaccine Market Size Market Share by Country in 2024
Figure 82. Brazil Group A and C Meningococcal Polysaccharide Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Group A and C Meningococcal Polysaccharide Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Group A and C Meningococcal Polysaccharide Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Group A and C Meningococcal Polysaccharide Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Group A and C Meningococcal Polysaccharide Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Group A and C Meningococcal Polysaccharide Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Group A and C Meningococcal Polysaccharide Vaccine Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Group A and C Meningococcal Polysaccharide Vaccine Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Group A and C Meningococcal Polysaccharide Vaccine Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Group A and C Meningococcal Polysaccharide Vaccine Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Group A and C Meningococcal Polysaccharide Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Group A and C Meningococcal Polysaccharide Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Group A and C Meningococcal Polysaccharide Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Group A and C Meningococcal Polysaccharide Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Group A and C Meningococcal Polysaccharide Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Group A and C Meningococcal Polysaccharide Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Group A and C Meningococcal Polysaccharide Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Group A and C Meningococcal Polysaccharide Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Group A and C Meningococcal Polysaccharide Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Group A and C Meningococcal Polysaccharide Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Group A and C Meningococcal Polysaccharide Vaccine Production Market Share by Region (2020-2025)
Figure 103. North America Group A and C Meningococcal Polysaccharide Vaccine Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Group A and C Meningococcal Polysaccharide Vaccine Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Group A and C Meningococcal Polysaccharide Vaccine Production (K Units) Growth Rate (2020-2025)
Figure 106. China Group A and C Meningococcal Polysaccharide Vaccine Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Group A and C Meningococcal Polysaccharide Vaccine Sales Forecast by Volume (2020-2033) & (K Units)
Figure 108. Global Group A and C Meningococcal Polysaccharide Vaccine Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Group A and C Meningococcal Polysaccharide Vaccine Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Group A and C Meningococcal Polysaccharide Vaccine Market Share Forecast by Type (2026-2033)
Figure 111. Global Group A and C Meningococcal Polysaccharide Vaccine Sales Forecast by Application (2026-2033)
Figure 112. Global Group A and C Meningococcal Polysaccharide Vaccine Market Share Forecast by Application (2026-2033)
Figure 1. Product Picture of Group A and C Meningococcal Polysaccharide Vaccine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Group A and C Meningococcal Polysaccharide Vaccine Market Size (M USD), 2024-2033
Figure 5. Global Group A and C Meningococcal Polysaccharide Vaccine Market Size (M USD) (2020-2033)
Figure 6. Global Group A and C Meningococcal Polysaccharide Vaccine Sales (K Units) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Group A and C Meningococcal Polysaccharide Vaccine Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Group A and C Meningococcal Polysaccharide Vaccine Product Life Cycle
Figure 13. Group A and C Meningococcal Polysaccharide Vaccine Sales Share by Manufacturers in 2024
Figure 14. Global Group A and C Meningococcal Polysaccharide Vaccine Revenue Share by Manufacturers in 2024
Figure 15. Group A and C Meningococcal Polysaccharide Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Group A and C Meningococcal Polysaccharide Vaccine Average Price (USD/Unit) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Group A and C Meningococcal Polysaccharide Vaccine Revenue in 2024
Figure 18. Industry Chain Map of Group A and C Meningococcal Polysaccharide Vaccine
Figure 19. Global Group A and C Meningococcal Polysaccharide Vaccine Market PEST Analysis
Figure 20. Global Group A and C Meningococcal Polysaccharide Vaccine Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Group A and C Meningococcal Polysaccharide Vaccine Market Share by Type
Figure 27. Sales Market Share of Group A and C Meningococcal Polysaccharide Vaccine by Type (2020-2025)
Figure 28. Sales Market Share of Group A and C Meningococcal Polysaccharide Vaccine by Type in 2024
Figure 29. Market Size Share of Group A and C Meningococcal Polysaccharide Vaccine by Type (2020-2025)
Figure 30. Market Size Share of Group A and C Meningococcal Polysaccharide Vaccine by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Group A and C Meningococcal Polysaccharide Vaccine Market Share by Application
Figure 33. Global Group A and C Meningococcal Polysaccharide Vaccine Sales Market Share by Application (2020-2025)
Figure 34. Global Group A and C Meningococcal Polysaccharide Vaccine Sales Market Share by Application in 2024
Figure 35. Global Group A and C Meningococcal Polysaccharide Vaccine Market Share by Application (2020-2025)
Figure 36. Global Group A and C Meningococcal Polysaccharide Vaccine Market Share by Application in 2024
Figure 37. Global Group A and C Meningococcal Polysaccharide Vaccine Sales Growth Rate by Application (2020-2025)
Figure 38. Global Group A and C Meningococcal Polysaccharide Vaccine Sales Market Share by Region (2020-2025)
Figure 39. Global Group A and C Meningococcal Polysaccharide Vaccine Market Size Market Share by Region (2020-2025)
Figure 40. North America Group A and C Meningococcal Polysaccharide Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Group A and C Meningococcal Polysaccharide Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Group A and C Meningococcal Polysaccharide Vaccine Sales Market Share by Country in 2024
Figure 43. North America Group A and C Meningococcal Polysaccharide Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Group A and C Meningococcal Polysaccharide Vaccine Market Size Market Share by Country in 2024
Figure 45. U.S. Group A and C Meningococcal Polysaccharide Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Group A and C Meningococcal Polysaccharide Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Group A and C Meningococcal Polysaccharide Vaccine Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Group A and C Meningococcal Polysaccharide Vaccine Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Group A and C Meningococcal Polysaccharide Vaccine Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Group A and C Meningococcal Polysaccharide Vaccine Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Group A and C Meningococcal Polysaccharide Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Group A and C Meningococcal Polysaccharide Vaccine Sales Market Share by Country in 2024
Figure 53. Europe Group A and C Meningococcal Polysaccharide Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Group A and C Meningococcal Polysaccharide Vaccine Market Size Market Share by Country in 2024
Figure 55. Germany Group A and C Meningococcal Polysaccharide Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Group A and C Meningococcal Polysaccharide Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Group A and C Meningococcal Polysaccharide Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Group A and C Meningococcal Polysaccharide Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Group A and C Meningococcal Polysaccharide Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Group A and C Meningococcal Polysaccharide Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Group A and C Meningococcal Polysaccharide Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Group A and C Meningococcal Polysaccharide Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Group A and C Meningococcal Polysaccharide Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Group A and C Meningococcal Polysaccharide Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Group A and C Meningococcal Polysaccharide Vaccine Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Group A and C Meningococcal Polysaccharide Vaccine Sales Market Share by Region in 2024
Figure 67. Asia Pacific Group A and C Meningococcal Polysaccharide Vaccine Market Size Market Share by Region in 2024
Figure 68. China Group A and C Meningococcal Polysaccharide Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Group A and C Meningococcal Polysaccharide Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Group A and C Meningococcal Polysaccharide Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Group A and C Meningococcal Polysaccharide Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Group A and C Meningococcal Polysaccharide Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Group A and C Meningococcal Polysaccharide Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Group A and C Meningococcal Polysaccharide Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Group A and C Meningococcal Polysaccharide Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Group A and C Meningococcal Polysaccharide Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Group A and C Meningococcal Polysaccharide Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Group A and C Meningococcal Polysaccharide Vaccine Sales and Growth Rate (K Units)
Figure 79. South America Group A and C Meningococcal Polysaccharide Vaccine Sales Market Share by Country in 2024
Figure 80. South America Group A and C Meningococcal Polysaccharide Vaccine Market Size and Growth Rate (M USD)
Figure 81. South America Group A and C Meningococcal Polysaccharide Vaccine Market Size Market Share by Country in 2024
Figure 82. Brazil Group A and C Meningococcal Polysaccharide Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Group A and C Meningococcal Polysaccharide Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Group A and C Meningococcal Polysaccharide Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Group A and C Meningococcal Polysaccharide Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Group A and C Meningococcal Polysaccharide Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Group A and C Meningococcal Polysaccharide Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Group A and C Meningococcal Polysaccharide Vaccine Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Group A and C Meningococcal Polysaccharide Vaccine Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Group A and C Meningococcal Polysaccharide Vaccine Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Group A and C Meningococcal Polysaccharide Vaccine Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Group A and C Meningococcal Polysaccharide Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Group A and C Meningococcal Polysaccharide Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Group A and C Meningococcal Polysaccharide Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Group A and C Meningococcal Polysaccharide Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Group A and C Meningococcal Polysaccharide Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Group A and C Meningococcal Polysaccharide Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Group A and C Meningococcal Polysaccharide Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Group A and C Meningococcal Polysaccharide Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Group A and C Meningococcal Polysaccharide Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Group A and C Meningococcal Polysaccharide Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Group A and C Meningococcal Polysaccharide Vaccine Production Market Share by Region (2020-2025)
Figure 103. North America Group A and C Meningococcal Polysaccharide Vaccine Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Group A and C Meningococcal Polysaccharide Vaccine Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Group A and C Meningococcal Polysaccharide Vaccine Production (K Units) Growth Rate (2020-2025)
Figure 106. China Group A and C Meningococcal Polysaccharide Vaccine Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Group A and C Meningococcal Polysaccharide Vaccine Sales Forecast by Volume (2020-2033) & (K Units)
Figure 108. Global Group A and C Meningococcal Polysaccharide Vaccine Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Group A and C Meningococcal Polysaccharide Vaccine Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Group A and C Meningococcal Polysaccharide Vaccine Market Share Forecast by Type (2026-2033)
Figure 111. Global Group A and C Meningococcal Polysaccharide Vaccine Sales Forecast by Application (2026-2033)
Figure 112. Global Group A and C Meningococcal Polysaccharide Vaccine Market Share Forecast by Application (2026-2033)
